ClinicalTrials.gov - Information on Clinical Trials and Human Research Studies: Browse: EORTC Early Clinical Studies Group


	Home	\|	Search	\|	Browse	\|	Resources	\|	Help	\|	What's New	\|	About

Browse : By Sponsor : University/Organization : EORTC Early Clinical Studies Group

Include trials that are no longer recruiting patients.

14 studies were found.
1. No longer recruiting Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme
Conditions: recurrent adult brain tumor; adult glioblastoma multiforme
2. No longer recruiting BIBX 1382 in Treating Patients With Solid Tumors
Condition: unspecified adult solid tumor, protocol specific
3. No longer recruiting Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer
Conditions: recurrent testicular cancer; recurrent ovarian germ cell tumor; testicular seminoma; extragonadal germ cell tumor
4. No longer recruiting E7070 in Treating Patients With Solid Tumors
Condition: unspecified adult solid tumor, protocol specific
5. No longer recruiting E7070 in Treating Patients With Stage IV Melanoma
Conditions: Stage IV Melanoma; Recurrent Melanoma
6. No longer recruiting Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors
Condition: Cancer
7. No longer recruiting Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme
Conditions: recurrent adult brain tumor; adult glioblastoma multiforme
8. No longer recruiting Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small cell Lung Cancer
Conditions: stage IIIA non-small cell lung cancer; stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; ...
9. No longer recruiting Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer
Conditions: recurrent pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
10. No longer recruiting ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma
Conditions: Stage IV Melanoma; stage IIIA non-small cell lung cancer; stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; ...
11. No longer recruiting MEN-10755 in Treating Adults With Recurrent or Refractory Solid Tumors
Condition: unspecified adult solid tumor, protocol specific
12. No longer recruiting MEN-10755 in Treating Patients With Solid Tumors
Conditions: unspecified adult solid tumor, protocol specific; testicular embryonal carcinoma and yolk sac tumor
13. No longer recruiting Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme
Condition: adult glioblastoma multiforme
14. No longer recruiting Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract
Conditions: Bladder Cancer; Kidney Cancer; Urethral Cancer

U.S. National Library of Medicine, Contact NLM Customer Service

National Institutes of Health, Department of Health & Human Services

1.	No longer recruiting	Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme Conditions: recurrent adult brain tumor; adult glioblastoma multiforme
2.	No longer recruiting	BIBX 1382 in Treating Patients With Solid Tumors Condition: unspecified adult solid tumor, protocol specific
3.	No longer recruiting	Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer Conditions: recurrent testicular cancer; recurrent ovarian germ cell tumor; testicular seminoma; extragonadal germ cell tumor
4.	No longer recruiting	E7070 in Treating Patients With Solid Tumors Condition: unspecified adult solid tumor, protocol specific
5.	No longer recruiting	E7070 in Treating Patients With Stage IV Melanoma Conditions: Stage IV Melanoma; Recurrent Melanoma
6.	No longer recruiting	Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors Condition: Cancer
7.	No longer recruiting	Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme Conditions: recurrent adult brain tumor; adult glioblastoma multiforme
8.	No longer recruiting	Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small cell Lung Cancer Conditions: stage IIIA non-small cell lung cancer; stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; ...
9.	No longer recruiting	Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer Conditions: recurrent pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
10.	No longer recruiting	ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma Conditions: Stage IV Melanoma; stage IIIA non-small cell lung cancer; stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; ...
11.	No longer recruiting	MEN-10755 in Treating Adults With Recurrent or Refractory Solid Tumors Condition: unspecified adult solid tumor, protocol specific
12.	No longer recruiting	MEN-10755 in Treating Patients With Solid Tumors Conditions: unspecified adult solid tumor, protocol specific; testicular embryonal carcinoma and yolk sac tumor
13.	No longer recruiting	Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme Condition: adult glioblastoma multiforme
14.	No longer recruiting	Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract Conditions: Bladder Cancer; Kidney Cancer; Urethral Cancer